Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00390884
What this trial is testing

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 173
Not applicableLooking for participantsNCT06998264
What this trial is testing

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children

Who this might be right for
Influenza Infection
University Hospital, Geneva 40
Not applicableStudy completedNCT01032980
What this trial is testing

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Who this might be right for
InfluenzaSwine-Origin A/H1N1 Influenza Virus
Sanofi Pasteur, a Sanofi Company 3,934
Post-approval studies (Phase 4)Ended earlyNCT03328325
What this trial is testing

Age and Response to Flu Vaccines

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 152
Early research (Phase 1)Study completedNCT00848887
What this trial is testing

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

Who this might be right for
Influenza
Novartis 410
Early research (Phase 1)Study completedNCT01033734
What this trial is testing

Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Who this might be right for
Influenza
Hoffmann-La Roche 8
Testing effectiveness (Phase 2)Study completedNCT00192179
What this trial is testing

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.

Who this might be right for
Influenza
MedImmune LLC 240
Large-scale testing (Phase 3)Study completedNCT03020628
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 171
Not applicableStudy completedNCT01705314
What this trial is testing

Trial of Vitamin D to Reduce Respiratory Infection

Who this might be right for
Respiratory Infection
McMaster University 1,300
Post-approval studies (Phase 4)Study completedNCT01246999
What this trial is testing

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Who this might be right for
Influenza
University of Rochester 34
Post-approval studies (Phase 4)Study completedNCT02549365
What this trial is testing

Efficacy & Safety of Nasal Influenza Immunisation in Children

Who this might be right for
Influenza Vaccines Efficacy and Safety
Imperial College London 276
Testing effectiveness (Phase 2)Study completedNCT01001169
What this trial is testing

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00192166
What this trial is testing

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Who this might be right for
Influenza
MedImmune LLC 1,200
Post-approval studies (Phase 4)UnknownNCT05389137
What this trial is testing

To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

Who this might be right for
Influenza
Wuhan Institute of Biological Products Co., Ltd 360
Not applicableStudy completedNCT01484522
What this trial is testing

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Who this might be right for
HIV-1 InfectionH1N1Influenza+1 more
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 149
Testing effectiveness (Phase 2)Study completedNCT00091702
What this trial is testing

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Who this might be right for
HIV InfectionsInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Study completedNCT02072174
What this trial is testing

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

Who this might be right for
Influenza and Acute Respiratory Viral Infections
Materia Medica Holding 569
Post-approval studies (Phase 4)Study completedNCT00138385
What this trial is testing

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 40
Post-approval studies (Phase 4)Study completedNCT01653015
What this trial is testing

Live Versus Inactivated Influenza Vaccine Study in Hutterite Children

Who this might be right for
Influenza
McMaster University 4,611
Large-scale testing (Phase 3)Study completedNCT01210898
What this trial is testing

Immunogenicity and Safety of V70P5 Revaccination Subjects

Who this might be right for
Influenza
Novartis Vaccines 197
Next Page